Role of herbal medicines to treat the symptoms of COVID-19 disease
Journal Title: TMR Clinical Research - Year 2021, Vol 4, Issue 2
Abstract
The need for effective therapeutic options for patients has received increasing attention in response to the prevalence of COVID 19. Although there are several options for the prevent of COVID-19, including vaccines, monoclonal antibodies, oligonucleotide-based therapies, peptides, and interferon therapies, no treatment for coronaviruses has yet been approved.
Authors and Affiliations
Mohammad Ali Zakeri1, Mahlagha Dehghan2*
Keywords
Related Articles
- EP ID EP695492
- DOI 10.12032/TMRCR20210522009
- Views 111
- Downloads 0
Role of herbal medicines to treat the symptoms of COVID-19 disease
The need for effective therapeutic options for patients has received increasing attention in response to the prevalence of COVID 19. Although there are several options for the prevent of COVID-19, including vacci...
Screening and bioinformatics analysis of thyroid cancer-related hub genes
Objective: To identify the thyroid cancer-related hub genes and pathways by bioinformatics initially in order to lay the foundation for further study. Methods: The expression profile chips and data of thyroid cancer were...
Optimal cut-off and assessment of survival days are needed in risk factors for COVID-19 mortality
We recently read the study published on The Lancet by Dr. Zhou and colleagues, entitled “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study”, wi...
Clinical observation of 36 patients with chronic nephritis proteinuria treated with Zhuangshen Gujing decoction
Objective: Our goal was to examine the impact of Zhuangshen Gujing decoction on proteinuria associated with chronic nephritis. Methods: 72 patients with chronic nephritis proteinuria were divided randomly into two groups...
The prognostic value of baseline circulating tumor cells in patients with metastatic breast cancer: a meta-analysis
Objective: The prognostic value of circulating tumor cells (CTCs) in metastatic breast cancer (MBC) patients was contentious. A meta-analysis was conducted to evaluate whether MBC patients’ clinical outcomes could be...